Ecs Botanics Holdings Stock Revenue
| ECS Stock | 0.02 0 6.67% |
ECS Botanics Holdings fundamentals help investors to digest information that contributes to ECS Botanics' financial success or failures. It also enables traders to predict the movement of ECS Stock. The fundamental analysis module provides a way to measure ECS Botanics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ECS Botanics stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 23 M | 14.5 M |
ECS | Revenue |
ECS Botanics Holdings Company Revenue Analysis
ECS Botanics' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current ECS Botanics Revenue | 20.03 M |
Most of ECS Botanics' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ECS Botanics Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of ECS
Projected quarterly revenue analysis of ECS Botanics Holdings provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of ECS Botanics match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in ECS Botanics' stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
ECS Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, ECS Botanics Holdings reported 20.03 M of revenue. This is 99.74% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The revenue for all Australia stocks is 99.79% higher than that of the company.
ECS Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ECS Botanics' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ECS Botanics could also be used in its relative valuation, which is a method of valuing ECS Botanics by comparing valuation metrics of similar companies.ECS Botanics is currently under evaluation in revenue category among its peers.
ECS Fundamentals
| Return On Equity | 0.076 | ||||
| Return On Asset | 0.0397 | ||||
| Profit Margin | 0.1 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 16.94 M | ||||
| Shares Outstanding | 1.3 B | ||||
| Shares Owned By Insiders | 36.69 % | ||||
| Price To Book | 0.73 X | ||||
| Price To Sales | 1.04 X | ||||
| Revenue | 20.03 M | ||||
| Gross Profit | 7.51 M | ||||
| EBITDA | 3.24 M | ||||
| Net Income | 1.92 M | ||||
| Cash And Equivalents | 1.87 M | ||||
| Total Debt | 1.02 M | ||||
| Book Value Per Share | 0.02 X | ||||
| Cash Flow From Operations | (1.49 M) | ||||
| Beta | 1.28 | ||||
| Market Capitalization | 20.74 M | ||||
| Total Asset | 32.88 M | ||||
| Retained Earnings | (8.73 M) | ||||
| Working Capital | 15.8 M | ||||
| Net Asset | 32.88 M |
About ECS Botanics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ECS Botanics Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ECS Botanics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ECS Botanics Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ECS Stock Analysis
When running ECS Botanics' price analysis, check to measure ECS Botanics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ECS Botanics is operating at the current time. Most of ECS Botanics' value examination focuses on studying past and present price action to predict the probability of ECS Botanics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ECS Botanics' price. Additionally, you may evaluate how the addition of ECS Botanics to your portfolios can decrease your overall portfolio volatility.